Does metformin improve egg quality in PCOS?

What does “egg quality” mean?

The phrase usually refers to an egg’s ability to mature, fertilise and support embryo development, but it is difficult to measure directly before treatment. Ovarian follicle counts, hormone levels, ovulation and pregnancy rates are related but distinct outcomes. Improvement in one does not prove improvement in another.

What is known about metformin in PCOS?

Metformin can improve insulin-related metabolic measures in some people and may influence menstrual or ovulatory function. Guidelines consider it for particular metabolic and reproductive contexts. This does not establish that it repairs eggs or improves their genetic or developmental quality.

What does fertility evidence show?

Studies vary in participants, treatment combinations and outcomes. Some report changes in ovulation or pregnancy measures, but evidence is not sufficient to make a broad claim that metformin improves egg quality or guarantees live birth. Fertility results depend on many factors, including age, sperm, tubal health and treatment context.

When might it be considered?

A clinician may consider metformin for PCOS-related metabolic indications or discuss it alongside fertility treatment in selected circumstances. For anovulatory infertility due to PCOS, current guidance identifies letrozole as first-line pharmacological ovulation induction when appropriate and where available. The right pathway requires individual assessment.

What should be discussed before treatment?

Clarify the intended outcome, expected duration, alternatives, side effects and monitoring. Gastrointestinal effects are common; kidney health and other conditions can affect suitability. If trying to conceive, review all medicines and supplements with a clinician and seek preconception advice.

A cautious bottom line

Do not take metformin solely on the promise of “better eggs.” Ask which measurable outcome treatment is intended to improve and what evidence supports that goal. Fertility care can investigate causes and discuss evidence-based options without overstating what any medicine can achieve.

Fertility decisions are broader than an egg-quality claim

If pregnancy is a goal, the first step is usually a fertility history and assessment, not an assumption that PCOS alone explains difficulty conceiving. A clinician may consider how often ovulation occurs and assess other relevant factors, including partner sperm and tubal health where indicated. Timing of referral depends on age, history and local pathways; seek advice sooner for absent periods or known fertility risks.

For anovulatory infertility due to PCOS with no other infertility factors, guideline-based treatment may include letrozole as first-line pharmacological ovulation induction, subject to suitability, local licensing and specialist advice. Metformin can be considered in selected circumstances, but it is not equivalent to an ovulation-induction plan and should not be prescribed on a promise of improved eggs. Pregnancy care should include review of medicines and metabolic health.

Before starting metformin, ask what outcome is expected, how progress will be measured and when treatment will be reviewed. Gastrointestinal effects are common; kidney function and other health conditions influence suitability. A healthcare professional can also explain what fertility tests can and cannot tell you. Neither follicle counts nor hormone values directly establish the developmental or genetic quality of an individual egg. Avoid claims that a drug “repairs” eggs or guarantees a healthy birth; these outcomes have not been established by the cited guidance.